ABC HOLDING
GenericsABC HOLDING is a generic drug manufacturer focused on Cardiovascular, Gastroenterology.
ABC HOLDING's Key Drugs
ABC HOLDING's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ABC HOLDING's Recent FDA Approvals
New NDA/BLA approvals for ABC HOLDING over the last two years — novel drugs only, excluding generics and label supplements.
ABC HOLDING's Therapeutic Areas
ABC HOLDING's approved drugs and pipeline span 2 therapeutic areas, led by Cardiovascular and Gastroenterology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ABC HOLDING's Top Competitors
ABC HOLDING's closest competitors by therapeutic-area and drug-target overlap include BAUSCH, Takeda, and APOTHECON. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ABC HOLDING Pipeline Snapshot
Active clinical trials for ABC HOLDING across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1977-02-07
- Latest
- 1998-11-03
- Applications
- 8